Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

NCT07252661 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Renal Cell Carcinoma
Thyroid Carcinoma, Medullary
Thyroid Carcinoma Primary Differentiated
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Melanoma
Gall Bladder Cancer
Advanced Solid Tumor

Interventions

DRUG: ACC-1898

Sponsor

AccSalus Biosciences, Inc.